OTC Healthcare in Russia
Euromonitor International's OTC Healthcare in Russia market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 114 | Publication date: Dec 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Health Standards Remain Low but Improve
Health levels remain low in Russia, with heavy smoking, poor diets and alcohol and drug abuse resulting in increasing rates of disease. This trend was further exacerbated by an ageing population. The deteriorating health of the Russian population, coupled with rising disposable income levels, resulted in more consumers purchasing a wider variety of OTC healthcare more frequently. Simultaneously, players launched more products to take advantage of sales dynamism and chained chemists/pharmacies continued to expand across the country. These factors therefore supported strong overall growth in OTC healthcare in 2006 over the previous year.
NRT Smoking Cessation Aids Dynamic but from Low Base
NRT smoking cessation aids saw the strongest current value growth in 2006 over the previous year. However, this was chiefly due to a low base, with these products first gaining a significant presence in 2005. These products are proving increasingly popular but sales remain largely limited to the major cities. There is a huge smoking population in Russia but most are unaware of or uninterested in the potential risks of smoking. Strong consumer education campaigns will be required to support stronger growth.
Fragmented Sales Led by Multinationals
OTC healthcare is extremely fragmented, with a large range of players. The leaders are multinationals, including Novartis, Berlin Chemie, Aventis, GlaxoSmithKline and Krka. These players benefit from high quality products and strong funds for investment in new product development and marketing. With rising disposable income levels, many consumers traded up from domestic generics and unbranded products to products from multinationals, which are often viewed as offering higher quality.
Consumers Prefer Specialised Distribution Outlets
Chemists/pharmacies continued to be the most significant distribution channel for OTC healthcare during the review period. Most consumers prefer this channel, believing it to offer expert advice. In addition, its lead was supported by the expansion of chains across Russia. Direct sales is also significant, however, particularly in vitamins and dietary supplements. Grocery outlets is meanwhile fairly undeveloped, with only larger urban outlets offering a limited range of vitamins and dietary supplements.
Faster Growth in Forecast Period
OTC healthcare is expected to see even stronger constant value growth during the forecast period. Growth will be partly underpinned by increasing consumer demand, driven by rising disposable income levels, a growing interest in health and widening awareness of OTC healthcare. In addition, growth will be driven by players, with more players expected to enter this dynamic area during the forecast period, often through the acquisition of or investment in local producers. Players will launch numerous value-added products, with a growing focus on quality as they attempt to meet changing consumer demands. Finally, the spread of chained chemists/pharmacies across the regions will make a wider range of OTC healthcare available to more consumers during the forecast period.
Table of contents
OTC HEALTHCARE IN RUSSIA : MARKET INSIGHT
EXECUTIVE SUMMARY
Health Standards Remain Low but Improve
NRT Smoking Cessation Aids Dynamic but from Low Base
Fragmented Sales Led by Multinationals
Consumers Prefer Specialised Distribution Outlets
Faster Growth in Forecast Period
KEY TRENDS AND DEVELOPMENTS
Growing State Funding Supports Increased Sales
Rx Medicines Still Dominate
Competition from Homeopathy Intensifies
Counterfeiting Still Huge but Losing Appeal
Rising Foreign Investment Results in More Consolidated Shares
Chained Chemists/Pharmacies Increasingly Significant
CITY KEY TRENDS AND DEVELOPMENTS
Moscow
St Petersburg
MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 Sales of OTC Healthcare by City: Value 2001-2006
Table 5 Sales of OTC Healthcare by City: % Value Growth 2001-2006
Table 6 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 7 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
Table 12 Forecast Sales of OTC Healthcare by City: Value 2006-2011
Table 13 Forecast Sales of OTC Healthcare by City: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification
De-listing or De-reimbursement
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Generics
Consumer Expenditure on Health Goods and Medical Services
Table 14 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
LOCAL COMPANY PROFILES - RUSSIA
AKRIKHIN OAO - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Akrikhin OAO: Key Facts
Summary 3 Akrikhin OAO: Operational Indicators 2004-2006
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Akrikhin OAO: Competitive Position 2006
EVALAR ZAO - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Evalar ZAO: Key Facts
Summary 6 Evalar ZAO: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 7 Evalar ZAO: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 8 Evalar ZAO: Competitive Position 2006
KRKA PHARMA OOO - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 9 Krka Pharma OOO: Key Facts
Summary 10 Krka dd/ Krka Pharma OOO: Operational Indicators 2006
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 11 Krka Pharma OOO: Competitive Position 2006
NATURPRODUKT EUROPE BV - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 12 NaturProdukt Europe BV: Key Facts
Summary 13 NaturProdukt Europe BV: Operational Indicators 2004-2005
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 14 NaturProdukt Europe BV: Competitive Position 2006
NIZHPHARM AO - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 15 Nizhpharm OAO: Key Facts
Summary 16 Nizhpharm OAO: Operational Indicators 2004-2006
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 17 Nizhpharm OAO: Competitive Position 2006
OTECHESTVENNYE LEKARSTVA GROUP - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 18 Otechestvennye Lekarstva Group: Key Facts
Summary 19 Otechestvennye Lekarstva Group: Operational Indicators 2005-2006
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 20 Schelkovsky Vitaminy Zavod: Competitive Position 2006
Summary 21 Novosibkhimpharm AOOT: Competitive Position 2006
PHARMSTANDARD GROUP - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 22 Pharmstandard Group: Key Facts
Summary 23 Pharmstandard Group: Operational Indicators 2004-2006
COMPANY BACKGROUND
PRODUCTION
Summary 24 Pharmstandard Group: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 25 Pharmstandard Group: Competitive Position 2006
RANBAXY LABORATORIES LTD - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 26 Ranbaxy Laboratories limited: Key Facts
Summary 27 Ranbaxy Laboratories limited: Operational Indicators 2004-2006
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 28 Ranbaxy Laboratories Ltd: Competitive Position 2006
VEROPHARM ZAO - OTC HEALTHCARE - RUSSIA
STRATEGIC DIRECTION
KEY FACTS
Summary 29 Veropharm ZAO: Key Facts
Summary 30 Veropharm ZAO: Operational Indicators 2004-2006
COMPANY BACKGROUND
PRODUCTION
Summary 31 Veropharm ZAO: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 32 Veropharm ZAO: Competitive Position 2006
ANALGESICS IN RUSSIA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 15 Sales of Analgesics by Subsector: Value 2001-2006
Table 16 Sales of Analgesics by Subsector: % Value Growth 2001-2006
Table 17 Herbal vs Standard Topical Analgesics 2001/2006
Table 18 Analgesics Company Shares by Retail Value 2002-2006
Table 19 Analgesics Brand Shares by Retail Value 2003-2006
Table 20 Forecast Sales of Analgesics by Subsector: Value 2006-2011
Table 21 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN RUSSIA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 22 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
Table 23 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
Table 24 Sales of Decongestants by Type: Value 2001-2006
Table 25 Sales of Decongestants by Type: % Value Growth 2001-2006
Table 26 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006
Table 27 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006
Table 28 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
Table 29 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
Table 30 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
Table 31 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
Table 32 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011
DIGESTIVE REMEDIES IN RUSSIA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 33 Sales of Digestive Remedies by Subsector: Value 2001-2006
Table 34 Sales of Digestive Remedies by Subsector: % Value Growth 2001-2006
Table 35 Herbal vs Standard Digestive Remedies 2001/2006
Table 36 Digestive Remedies Company Shares by Retail Value 2002-2006
Table 37 Digestive Remedies Brand Shares by Retail Value 2003-2006
Table 38 Forecast Sales of Digestive Remedies by Subsector: Value 2006-2011
Table 39 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2006-2011
MEDICATED SKIN CARE IN RUSSIA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 40 Sales of Medicated Skin Care by Subsector: Value 2001-2006
Table 41 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
Table 42 Herbal vs Standard Medicated Skin Care 2001/2006
Table 43 Medicated Skin Care Company Shares by Retail Value 2002-2006
Table 44 Medicated Skin Care Brand Shares by Retail Value 2003-2006
Table 45 Acne Treatments Brand Shares by Retail Value 2003-2006
Table 46 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
Table 47 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011
VITAMINS AND DIETARY SUPPLEMENTS IN RUSSIA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 48 Sales of Vitamins and Dietary Supplements by Subsector: Value 2001-2006
Table 49 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2001-2006
Table 50 Sales of Vitamins by Type: Value 2001-2006
Table 51 Sales of Vitamins by Type: % Value Growth 2001-2006
Table 52 Vitamins and Dietary Supplements Company Shares by Retail Value 2002-2006
Table 53 Vitamins and Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 54 Vitamins Brand Shares by Retail Value 2003-2006
Table 55 Sales of Dietary Supplements by Type: Value 2001-2006
Table 56 Sales of Dietary Supplements by Type: % Value Growth 2001-2006
Table 57 Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 58 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2006-2011
Table 59 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2006-2011
NRT SMOKING CESSATION AIDS IN RUSSIA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 60 Number of Smokers by Gender 2001-2006
SECTOR DATA
Table 61 Sales of Smoking Cessation Aids by Subsector: Value 2001-2006
Table 62 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2001-2006
Table 63 Smoking Cessation Aids Company Shares by Retail Value 2002-2006
Table 64 Smoking Cessation Aids Brand Shares by Retail Value 2003-2006
Table 65 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2006-2011
Table 66 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2006-2011
EYE CARE IN RUSSIA
OVERVIEW
SECTOR DATA
Table 67 Sales of Eye Care by Subsector: Value 2001-2006
Table 68 Sales of Eye Care by Subsector: % Value Growth 2001-2006
Table 69 Eye Care Company Shares by Retail Value 2002-2006
Table 70 Eye Care Brand Shares by Retail Value 2003-2006
Table 71 Forecast Sales of Eye Care by Subsector: Value 2006-2011
Table 72 Forecast Sales of Eye Care by Subsector: % Value Growth 2006-2011
EAR CARE IN RUSSIA
OVERVIEW
ADULT MOUTHCARE IN RUSSIA
OVERVIEW
CALMING AND SLEEPING PRODUCTS IN RUSSIA
OVERVIEW
WOUND TREATMENTS IN RUSSIA
OVERVIEW
SECTOR DATA
Table 73 Sales of Wound Treatments by Subsector: Value 2001-2006
Table 74 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
Table 75 Wound Treatments Company Shares by Retail Value 2002-2006
Table 76 Wound Treatments Brand Shares by Retail Value 2003-2006
Table 77 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
Table 78 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011
EMERGENCY CONTRACEPTION IN RUSSIA
OVERVIEW
SECTOR DATA
Table 79 Sales of Emergency Contraception by Subsector: Value 2001-2006
Table 80 Sales of Emergency Contraception by Subsector: % Value Growth 2001-2006
Table 81 Forecast Sales of Emergency Contraception by Subsector: Value 2006-2011
Table 82 Forecast Sales of Emergency Contraception by Subsector: % Value Growth 2006-2011